RESEARCH DATABASE

InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition. With our long history in the industry, we provide more than 7,000 research publications.

Printable list of studies

Download Annual Studies PDF

Use the search box below to find key terms in research papers. For category-specific or recommended results, use the dropdown lists provided.
Research title with ★ indicates InBody recommended paper.

The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease

Nephrology
Author
Ohara et al.
Used Parameters : ICW, ECW, TBW, ECW/TBW
Publication Year : 2020
Country : Japan
Journal : Diabetology & Metabolic Syndrome
Sodium–glucose cotransporter 2 (SGLT2) inhibitors are an antihyperglycemic drug with diuretic action. We recently reported that the SGLT2 inhibitor dapagliflozin ameliorates extracellular volume expansion with a mild increase in urine volume. However, the impact of the pretreatment extracellular volume status on the body fluid response to SGLT2 inhibitors remains unclear. Thirty-six diabetic kidney disease (DKD) patients were treated with dapagliflozin. The body fluid volume, including intracellular water (ICW), extracellular water …
Full text
List
Powered by KBoard